Cargando…

Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment

Malnutrition and sarcopenia are prevalent in patients with head and neck squamous cell carcinoma (HNSCC). Pre-treatment sarcopenia and adverse oncological outcomes in this population are well described. The impact of myosteatosis and post-treatment sarcopenia is less well known. Patients with HNSCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahern, Elizabeth, Brown, Teresa Ellen, Campbell, Louise, Hughes, Brett G. M., Banks, Merrilyn, Lin, Charles Y., Kenny, Lizbeth M., Bauer, Judith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876810/ https://www.ncbi.nlm.nih.gov/pubmed/35152926 http://dx.doi.org/10.1017/S0007114522000435

Ejemplares similares

Protocol for a randomized controlled trial of early prophylactic feeding via gastrostomy versus standard care in high risk patients with head and neck cancer
por: Brown, Teresa, et al.
Publicado: (2014)

Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer
por: Brown, Teresa E, et al.
Publicado: (2017)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort
por: Meister, Franziska Alexandra, et al.
Publicado: (2022)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

A qualitative comparison of the nutrition care experiences of carers supporting patients with head and neck cancer throughout surgery and radiation treatment and survivorship
por: Hiatt, Joanne, et al.
Publicado: (2022)

A Retrospective Cohort Study of Myosteatosis and Quality of Life in Head and Neck Cancer Patients
por: Shaver, Amy L., et al.
Publicado: (2021)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer
por: Srpcic, Matevz, et al.
Publicado: (2020)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults
por: Tan, Lingling, et al.
Publicado: (2021)

Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy
por: Chou, Wen-Chi, et al.
Publicado: (2022)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
por: Westenberg, Lisa B., et al.
Publicado: (2022)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality
por: Engelmann, Simon U., et al.
Publicado: (2023)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
por: West, Malcolm A., et al.
Publicado: (2019)

Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
por: Banierink, Hester, et al.
Publicado: (2021)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Sarcopenia and Myosteatosis Assessed by Magnetic Resonance Enterography May Predict Negative Outcomes in Patients with Crohn’s Disease
por: Eren Cankurtaran, Rasim, et al.
Publicado: (2023)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer
por: Vangelov, Belinda, et al.
Publicado: (2023)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
por: Chen, Qi, et al.
Publicado: (2022)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022)

Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation
por: Lazarev, Stanislav, et al.
Publicado: (2017)

A Survey of Home Enteral Nutrition Practices and Reimbursement in the Asia Pacific Region
por: Wong, Alvin, et al.
Publicado: (2018)

Sarcopenia in head and neck cancer: A scoping review
por: Jovanovic, Nedeljko, et al.
Publicado: (2022)

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
por: Montano‐Loza, Aldo J., et al.
Publicado: (2015)

Computed Tomography-Derived Myosteatosis and Metabolic Disorders
por: Miljkovic, Iva, et al.
Publicado: (2021)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography‐defined sarcopenia assessment in patients with head and neck cancer
por: Vangelov, Belinda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jca03gnslcphfe0pmi7n452eto